Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Labopharm and Sepracor to develop solid oral form of levalbuterol

Jan. 23, 1997

New antiasthma agents from Tanabe Seiyaku

Jan. 23, 1997

SmithKline Beecham reports new antiinflammatory/antiallergic agents

Jan. 23, 1997

TBC cell adhesion inhibitor enters clinic

Jan. 22, 1997

Celltech reports new PDE IV inhibitors

Jan. 21, 1997

cAMP PDE inhibitors disclosed by Nippon Kayaku

Jan. 20, 1997

Therapeutically active glycomimetic saccharopeptides from Glycomed

Jan. 17, 1997

Schering-Plough develops dual PAF and histamine antagonist

Jan. 16, 1997

New antihistamines in the pipeline at HMR

Jan. 16, 1997

Inhale/Centeon agreement for alpha1-proteinase inhibitor

Jan. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...